The Role of AI in Diagnosing Rare Diseases Faster

For many patients with a rare disease, getting a diagnosis can be a long and frustrating journey.

A patient may visit several doctors, undergo repeated tests, receive different possible diagnoses, and sometimes spend years searching for an explanation for symptoms that do not fit a common disease.

This is often called the diagnostic odyssey.

Rare diseases are difficult to diagnose partly because they are uncommon individually, symptoms can overlap with more common conditions, and many physicians may encounter a particular rare disease only rarely in their careers.

Artificial intelligence is beginning to offer a new approach.

Instead of relying only on a physician’s memory or searching through medical literature manually, AI systems can analyze large amounts of clinical information, identify patterns across symptoms, compare phenotypes with known diseases, examine genetic information, and generate ranked diagnostic possibilities.

Recent research demonstrates just how quickly this field is developing.

In February 2026, researchers published a Nature study describing DeepRare, an AI-based multi-agent system designed to support rare-disease differential diagnosis. The system combines clinical information, Human Phenotype Ontology terms, genetic testing results, specialized tools, and medical knowledge sources to generate ranked diagnostic hypotheses with traceable reasoning.

This raises an important question:

Can AI finally make rare-disease diagnosis faster?

The answer is promising—but AI should currently be viewed as a clinical decision-support tool, not an autonomous doctor.

Also Read: AI-Assisted Colonoscopy: How Polyp Detection Tools Are Changing GI Care

What Are Rare Diseases?

A rare disease is a condition that affects a relatively small proportion of the population.

Although each individual rare disease may affect relatively few people, the total number of people living with rare diseases is substantial.

Current estimates commonly put the worldwide rare-disease population at more than 300 million people, with thousands of distinct rare diseases recognized.

Many rare diseases are genetic, but rare diseases can also result from other biological, infectious, autoimmune, metabolic, or environmental causes.

Examples include:

• Huntington disease
• Cystic fibrosis
• Marfan syndrome
• Ehlers-Danlos syndromes
• Pompe disease
• Wilson disease
• Fabry disease
• Rett syndrome
• Gaucher disease
• Many rare neurological and metabolic disorders

The challenge is that symptoms can vary significantly between patients.

One person may have a classic presentation, while another may have only a subset of the expected symptoms.

That complexity makes rare diseases an especially interesting application for AI.

Also Read: StockMarket Trend Prediction Model 

Why Are Rare Diseases So Difficult to Diagnose?

The Symptoms Can Be Extremely Diverse

A single rare disease may affect several organs or systems.

For example, a genetic disorder might involve:

• The nervous system
• Heart
• Kidneys
• Muscles
• Eyes
• Skin

A doctor may initially encounter each symptom separately.

AI can potentially help connect these apparently unrelated findings.

Doctors May Have Limited Exposure

A physician may be highly experienced but still have never personally encountered a particular rare condition.

There are simply too many rare diseases for any individual clinician to memorize all of them.

AI can search across large medical knowledge bases much faster than a human can manually review thousands of possibilities.

Rare Diseases Can Resemble Common Diseases

This creates another problem.

A patient may initially receive a diagnosis for a common condition because the early symptoms look familiar.

If treatment does not work as expected, physicians may need to reconsider the diagnosis.

AI could potentially help identify unusual combinations of symptoms that suggest a less common explanation.

Also Read: Can AI Really Predict Heart Attacks Before They Happen?

What Is the “Diagnostic Odyssey”?

The diagnostic odyssey describes the prolonged process many patients experience before receiving an accurate rare-disease diagnosis.

It can involve:

Symptoms → First doctor → Initial diagnosis → Treatment → Symptoms continue → Specialist referral → More tests → New diagnosis → Genetic testing → Further investigation

This process can be physically, emotionally, and financially exhausting.

A 2026 Nature article described the rare-disease diagnostic journey as often exceeding five years, involving repeated referrals, misdiagnoses, and unnecessary interventions.

AI cannot eliminate every part of this journey.

But it may help shorten the stage where doctors are trying to determine:

“What could possibly explain all of these symptoms?”

How Does AI Help Diagnose Rare Diseases?

AI can approach rare-disease diagnosis as a pattern-recognition and information-integration problem.

Instead of examining one piece of information at a time, AI can combine many sources.

These may include:

• Symptoms
• Clinical notes
• Medical history
• Laboratory results
• Imaging
• Genetic variants
• Family history
• Physical examination findings
• Phenotype information
• Previous diagnoses
• Published medical literature

The system can then generate a list of possible diagnoses and rank them according to the available evidence.

Step 1: AI Extracts Important Symptoms

Much of the information in healthcare exists as unstructured text.

A physician may write:

“Patient has progressive muscle weakness, difficulty walking, elevated creatine kinase, and a family history of similar symptoms.”

A human physician understands these clues.

AI can convert the text into structured clinical concepts.

Natural language processing (NLP) systems can identify relevant findings and connect them to standardized medical terminology.

This is particularly valuable because electronic health records contain enormous amounts of information that may otherwise be difficult to search systematically.

A 2025 study published in npj Digital Medicine demonstrated this approach using a phenotype-based AI pipeline called PhenoBrain. It extracted phenotypes from electronic health records and used multiple diagnostic models to generate differential diagnoses across 2,271 cases involving 431 rare diseases.

Step 2: AI Connects Symptoms to Phenotypes

A phenotype is an observable characteristic or trait associated with a disease.

Examples include:

• Short stature
• Seizures
• Muscle weakness
• Abnormal facial features
• Hearing loss
• Developmental delay
• Heart abnormalities
• Vision problems

Rare-disease researchers commonly use standardized phenotype vocabularies such as the Human Phenotype Ontology (HPO).

AI can compare a patient’s phenotype profile with known disease profiles.

The more specific the combination of findings, the more useful this approach can become.

Step 3: AI Can Analyze Genetic Information

Genetic testing has become an important part of diagnosing many rare diseases.

But genetic sequencing can produce a huge number of variants.

The challenge is not simply finding genetic variants.

It is determining:

Which variant could actually explain the patient’s condition?

AI and computational tools can help prioritize variants by considering:

• Gene-disease relationships
• Inheritance patterns
• Patient phenotypes
• Variant characteristics
• Population frequency
• Existing scientific evidence

This can help clinicians focus on the most plausible explanations.

Step 4: AI Searches Medical Knowledge

Rare-disease knowledge is constantly changing.

New diseases are discovered.

New genes are linked to existing diseases.

New symptoms are reported.

New diagnostic criteria are published.

A physician cannot realistically memorize every update.

AI systems can potentially search and integrate current medical knowledge sources to support diagnostic reasoning.

The 2026 DeepRare study is notable because its system uses multiple specialized tools and external knowledge sources rather than relying solely on the language model’s internal knowledge. It generates diagnostic hypotheses with links to verifiable evidence.

This is important because traceability matters in medicine.

A doctor needs to know not only what AI suggests, but also why it suggests it.

Step 5: AI Creates a Differential Diagnosis

A differential diagnosis is a list of possible conditions that could explain a patient’s symptoms.

AI can rank potential diagnoses.

For example:

Possible diagnosis 1 — high probability

Possible diagnosis 2 — moderate probability

Possible diagnosis 3 — lower probability

The clinician can then investigate the most relevant possibilities.

This can potentially reduce the time spent searching through hundreds or thousands of diseases.

DeepRare: A Major 2026 Development

One of the most significant recent developments is DeepRare, described in a February 2026 Nature paper.

DeepRare is an agentic AI system designed specifically for rare-disease differential diagnosis.

Instead of functioning as a simple chatbot, it uses multiple specialized components and tools.

It can process:

• Free-text clinical descriptions
• Human Phenotype Ontology terms
• Genetic testing results
• Medical literature
• Clinical knowledge
• Existing patient cases

The system was evaluated across nine datasets spanning 14 medical specialties and 2,919 diseases.

In phenotype-based testing, DeepRare achieved a reported average Recall@1 of 57.18%, outperforming the next-best method by 23.79%. In a multimodal test involving 168 cases, it achieved 69.1% compared with 55.9% for Exomiser. Expert reviewers agreed with 95.4% of its reasoning chains in the reported evaluation.

These numbers are impressive.

But they should not be interpreted as meaning that DeepRare can diagnose 57% of real-world patients correctly without physician involvement.

The study evaluates specific datasets and tasks.

Benchmark performance is not the same as real-world clinical effectiveness.

That distinction is essential when evaluating medical AI.

Also Read: AI in Medical Imaging: What Radiologists Need to Know in 2026

AI Can Help Doctors Think Beyond the Obvious Diagnosis

One of the most valuable potential benefits of AI is helping clinicians consider diagnoses they might not immediately think of.

A physician may see:

symptom A + symptom B + symptom C

and initially consider a common condition.

AI may identify:

A + B + C + D + genetic finding E

as a pattern associated with a rare disease.

This does not mean the AI is always correct.

Instead, it can act as a diagnostic safety net.

It can remind clinicians:

“There may be another explanation worth investigating.”

AI and Medical Imaging in Rare Diseases

Medical imaging is another important source of diagnostic information.

AI can analyze:

• MRI
• CT
• X-rays
• Ultrasound
• PET scans
• Retinal images
• Pathology images

Some rare diseases have characteristic imaging patterns.

AI can potentially identify these patterns and connect them with clinical and genetic information.

For example, an AI system could theoretically combine:

MRI pattern + neurological symptoms + family history + genetic variant

to prioritize a particular rare neurological disorder.

This is an example of multimodal AI.

Instead of analyzing each data type independently, multimodal systems attempt to reason across different forms of information.

The Rise of Multimodal AI

The future of rare-disease diagnosis may involve AI systems that can simultaneously understand:

Text + Images + Genetics + Laboratory Data + Medical Literature

This is fundamentally different from traditional diagnostic software.

A multimodal AI system could potentially read a clinical note, interpret an image, analyze genetic results, and search relevant medical literature.

Research published in Nature Medicine in 2025 described advances in generalist medical language models capable of supporting diagnosis across specialties, including common and rare diseases.

Generative AI research is also moving toward more complex systems involving agents, reasoning models, and multimodal capabilities.

What Are the Benefits of AI for Rare Disease Diagnosis?

1. Faster Differential Diagnosis

AI can rapidly compare patient findings against large disease databases.

2. Recognition of Unusual Patterns

Machine-learning systems can identify combinations of symptoms that may be difficult to connect manually.

3. Better Use of Genetic Data

AI can help prioritize genetic variants and connect them with patient phenotypes.

4. Access to Large Medical Knowledge Bases

AI can process enormous amounts of medical literature and structured disease information.

5. Support for General Clinicians

AI may help clinicians who do not specialize in rare diseases recognize when a patient requires further investigation.

6. Potentially Fewer Unnecessary Tests

If the differential diagnosis becomes more focused earlier, physicians may be able to choose more targeted investigations.

This possibility requires real-world validation, but it is an important potential benefit.

7. Earlier Specialist Referral

AI could flag cases that may benefit from referral to a genetics clinic or rare-disease specialist.

Also Read: How AI is Improving Early Cancer Detection in Radiology | Nudrat Abbas

The Challenges of Using AI for Rare Diseases

The potential is enormous, but rare diseases create unique AI challenges.

Limited Training Data

This may be the biggest challenge.

If a disease affects only a small number of people, there may be very few high-quality cases available for training.

DeepRare’s authors specifically identify limited cases and data scarcity as major challenges for rare-disease AI development.

Rare Diseases Are Extremely Heterogeneous

The same disease can present differently in different people.

Age, genetics, environment, and other biological factors can influence symptoms.

This makes simple pattern matching insufficient.

AI Can Hallucinate

Generative AI systems can produce information that sounds convincing but is incorrect.

In medicine, this can be dangerous.

An AI system might invent:

• A nonexistent disease association
• An incorrect gene relationship
• A fabricated research citation
• An unsupported diagnosis

This is why evidence retrieval and traceable reasoning are increasingly important.

The Importance of Explainable AI

Doctors cannot simply receive an AI output saying:

“Diagnosis: Disease X.”

They need to understand why.

A trustworthy rare-disease AI system should ideally provide:

• The suspected diagnosis
• Supporting symptoms
• Relevant phenotype matches
• Genetic evidence
• Contradictory findings
• Confidence information
• Supporting literature
• Recommended next diagnostic steps

This creates a more transparent decision-support process.

The DeepRare research specifically emphasizes traceable reasoning and evidence-linked diagnostic hypotheses.

AI Bias and Health Inequality

AI systems can inherit biases from their training data.

If a dataset contains mostly patients from one geographic region or ancestry group, the model may perform differently for other populations.

This is particularly important for rare diseases because many datasets are already small.

A system trained on a limited number of patients may appear highly accurate while failing when used in a different population.

A 2026 systematic review of NLP and LLM applications for rare-disease phenotyping and diagnosis highlighted data scarcity, generalization, interpretability, fairness, privacy, and inconsistent evaluation as continuing challenges.

Therefore, future rare-disease AI needs diverse, multicenter, internationally validated datasets.

AI Should Assist Doctors—Not Replace Them

The most important principle is simple:

AI should support clinical reasoning, not replace clinical judgment.

A rare-disease diagnosis can have major consequences.

It can affect:

• Treatment
• Genetic counseling
• Family planning
• Insurance
• Psychological well-being
• Long-term monitoring
• Family members who may also be at risk

A physician must therefore verify the diagnosis.

AI can help answer:

“What should we consider?”

But the clinical team must determine:

“What is actually true for this patient?”

How AI Could Change the Diagnostic Journey

Consider a patient with several unexplained symptoms.

Traditional pathway

Symptoms → General practitioner → Specialist → Tests → Another specialist → Genetic testing → More testing → Possible diagnosis

This can take years.

AI-assisted pathway

Symptoms → AI-assisted phenotype extraction → Differential diagnosis → Targeted testing → Specialist review → Genetic confirmation → Diagnosis

AI does not remove every step.

But it may help clinicians reach the right questions earlier.

That could potentially reduce unnecessary referrals and repeated testing.

AI Could Help Find Previously Undiagnosed Patients

Another exciting application is case finding.

Instead of waiting for a doctor to recognize a rare disease, AI could scan electronic health records and identify patients whose combination of symptoms, tests, and medical history resembles a known rare condition.

For example, an AI system could identify patients who have:

• Multiple unexplained hospitalizations
• Repeated abnormal laboratory results
• A characteristic combination of symptoms
• Repeated specialist visits
• Unexplained genetic findings

The system could then flag the record for clinical review.

This is sometimes described as phenotype-driven case finding.

The goal is not to automatically diagnose the patient.

It is to identify people who may deserve a closer look.

The Future of AI in Rare Disease Diagnosis

The next generation of systems will likely become more multimodal and agentic.

Instead of one model answering one question, multiple AI agents may work together.

For example:

Agent 1: Clinical Phenotyping

Extracts symptoms and clinical findings.

Agent 2: Genetic Analysis

Examines genetic variants.

Agent 3: Medical Literature

Searches current scientific evidence.

Agent 4: Imaging Analysis

Reviews relevant medical images.

Agent 5: Differential Diagnosis

Combines the evidence.

Agent 6: Evidence Verification

Checks whether the supporting evidence is reliable.

Physician

Reviews the complete case and makes the final clinical decision.

This type of architecture is already being explored in research such as DeepRare.

What Will Rare Disease Diagnosis Look Like in the Future?

The long-term vision is a healthcare system where AI can continuously analyze clinical information and identify unusual patterns much earlier.

A patient might not need to wait until a specialist recognizes a rare disease.

Instead, an AI system could flag an unusual phenotype months or years earlier.

Imagine a medical record that automatically recognizes:

“This patient has an unusual combination of neurological, cardiac, and metabolic findings that warrants evaluation for a specific group of genetic disorders.”

That could change the diagnostic journey.

The patient could receive appropriate testing earlier.

The correct specialist could become involved sooner.

And potentially, treatment or disease management could begin earlier.

What AI Cannot Do Yet

Despite rapid progress, several limitations remain.

AI cannot guarantee a correct rare-disease diagnosis.

It cannot replace genetic confirmation when genetic confirmation is clinically required.

It cannot independently understand every patient’s circumstances.

It cannot eliminate the need for specialist expertise.

And benchmark results do not automatically translate into improved patient outcomes.

A recent systematic review and meta-analysis of LLM performance in rare-disease diagnosis found substantial heterogeneity across studies and emphasized that the evidence base is still developing.

This is why clinical validation matters.

The Importance of Clinical Validation

Before AI becomes a routine diagnostic tool, researchers need to answer several questions:

• Does it work across different populations?
• Does it work across different hospitals?
• Does it reduce diagnostic delays?
• Does it reduce unnecessary testing?
• Does it improve diagnostic accuracy?
• Does it improve patient outcomes?
• Does it introduce new errors?
• Can clinicians understand its reasoning?
• Is the system safe when its confidence is low?

In 2025, researchers published the STARD-AI reporting guideline to improve how diagnostic accuracy studies involving AI are reported. The guideline is intended to make evidence about AI diagnostic performance more transparent and useful for evaluating clinical technologies.

This is important because impressive AI demonstrations are not enough.

Healthcare needs reproducible clinical evidence.

Frequently Asked Questions – The Role of AI in Diagnosing Rare Diseases Faster

Can AI diagnose rare diseases?

AI can assist with rare-disease differential diagnosis by analyzing symptoms, phenotypes, clinical records, genetic information, and medical literature. However, AI-generated diagnoses should be reviewed and confirmed by qualified healthcare professionals.

Can AI make rare-disease diagnosis faster?

Potentially, yes. AI can rapidly process large amounts of clinical information and prioritize possible diagnoses. Research published in 2025 and 2026 demonstrates promising performance in rare-disease differential diagnosis.

What is the diagnostic odyssey?

The diagnostic odyssey refers to the often lengthy process of searching for an accurate diagnosis, which can involve multiple doctors, tests, referrals, misdiagnoses, and treatments.

How does AI use genetics to diagnose rare diseases?

AI can combine genetic variants with a patient’s symptoms and phenotypes to prioritize genes and diseases that may explain the patient’s condition.

Can AI replace genetic testing?

No. AI can help interpret and prioritize genetic information, but it does not replace clinically appropriate genetic testing or professional genetic interpretation.

What is phenotype-based AI?

Phenotype-based AI analyzes observable patient characteristics—such as symptoms, physical findings, and clinical measurements—and compares them with patterns associated with known diseases.

What is DeepRare?

DeepRare is an AI-based multi-agent system described in a 2026 Nature study for rare-disease differential diagnosis. It integrates clinical descriptions, phenotype terms, genetic information, specialized tools, and medical knowledge to generate ranked diagnostic hypotheses with traceable reasoning.

Will AI replace rare-disease specialists?

It is more likely that AI will become a tool used by specialists and general clinicians. Rare-disease specialists provide essential clinical judgment, interpretation, patient communication, and responsibility for final diagnosis and treatment.

Conclusion: The Role of AI in Diagnosing Rare Diseases Faster

Rare diseases have traditionally presented one of medicine’s most difficult diagnostic challenges.

Thousands of diseases, complex symptoms, limited clinical familiarity, fragmented medical information, and genetic complexity can make diagnosis slow and difficult.

Artificial intelligence offers a new approach.

AI can analyze clinical notes, extract phenotypes, compare symptoms against disease databases, prioritize genetic variants, search medical literature, analyze medical images, and generate ranked differential diagnoses.

Recent developments such as PhenoBrain and DeepRare demonstrate how quickly this field is advancing. The 2026 DeepRare study is particularly notable because it combines multiple information sources and specialized tools while attempting to make its reasoning traceable and evidence-based.

But the future of rare-disease diagnosis should not be about replacing doctors with machines.

It should be about giving doctors better information, earlier.

The most valuable AI system may not be the one that claims:

“I know the diagnosis.”

It may be the one that says:

“Here are the unusual patterns I found, here are the diseases that could explain them, here is the evidence, and here is what you should investigate next.”

That approach could help shorten diagnostic delays, reduce missed possibilities, and give patients a faster path toward answers.

AI cannot eliminate the complexity of rare diseases.

But it may help medicine recognize the right clues sooner.

And for patients who have spent years searching for a diagnosis, that could make an enormous difference.

Medical Disclaimer – The Role of AI in Diagnosing Rare Diseases Faster

This article is for educational and informational purposes only. Artificial intelligence tools discussed here are emerging technologies and should not be used as a substitute for professional medical diagnosis, genetic counseling, or treatment. AI-generated diagnostic suggestions require appropriate clinical validation and review by qualified healthcare professionals.